Online first
Short communication
Published online: 2024-10-22
Enhanced complement consumption and histone H3 citrullination predict disease severity and early mortality risk in non-high-risk pulmonary embolism
Abstract
Not available
References
- Konstantinides SV, Meyer G, Becattini C, et al. ESC Scientific Document Group, The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS): The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Respir J. 2019; 54(3): 543–603.
- Silva BV, Calé R, Menezes MN, et al. How to predict prognosis in patients with acute pulmonary embolism? Recent advances. Kardiol Pol. 2023; 81(7-8): 684–691.
- Cosmi B, Legnani C, Libra A, et al. D-Dimers in diagnosis and prevention of venous thrombosis: recent advances and their practical implications. Pol Arch Intern Med. 2023; 133(11).
- Stark K, Massberg S. Interplay between inflammation and thrombosis in cardiovascular pathology. Nat Rev Cardiol. 2021; 18(9): 666–682.
- Weitz JI, Chan NC. Novel antithrombotic strategies for treatment of venous thromboembolism. Blood. 2020; 135(5): 351–359.
- Natorska J, Ząbczyk M, Undas A. Neutrophil extracellular traps (nets) in cardiovascular diseases: from molecular mechanisms to therapeutic interventions. Kardiol Pol. 2023; 81(12): 1205–1216.
- Ząbczyk M, Natorska J, Janion-Sadowska A, et al. Prothrombotic fibrin clot properties associated with NETs formation characterize acute pulmonary embolism patients with higher mortality risk. Sci Rep. 2020; 10(1): 11433.
- Rostoff P, Ząbczyk M, Natorska J, et al. Complement activation is associated with right ventricular dysfunction and the severity of pulmonary embolism: links with prothrombotic state. J Thorac Dis. 2024; 16(5): 3181–3191.
- Sinkovits G, Mező B, Réti M, et al. Complement overactivation and consumption predicts in-hospital mortality in SARS-CoV-2 infection. Front Immunol. 2021; 12: 663187.
- Pieters M, Philippou H, Undas A, et al. Subcommittee on Factor XIII and Fibrinogen, and the Subcommittee on Fibrinolysis. An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH. J Thromb Haemost. 2018; 16(5): 1007–1012.
- Grosso G, Vikerfors A, Woodhams B, et al. Thrombin activatable fibrinolysis inhibitor (TAFI) - A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS). Thromb Res. 2017; 158: 168–173.
- Varjú I, Kolev K. Networks that stop the flow: a fresh look at fibrin and neutrophil extracellular traps. Thrombosis Research. 2019; 182: 1–11.
